FDA.reportPublic FDA data

RiaSTAP 1 MG Injection

RxCUI
831509
RxNorm name
RiaSTAP 1 MG Injection
Display name
RiaSTAP 1 MG Injection
Full name
RiaSTAP 1 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125317RiastapFibrinogen Concentrate (Human)351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
903dc8d0-39da-462c-9dac-004e0c7a26ccRiaSTAP 1 MG Injection [PSN] · fibrinogen, human 1 MG Injection [RiaSTAP] [SBD] · RiaSTAP 1 MG Injection [SY]319These highlights do not include all the information needed to use RIASTAP ® safely and effectively. See full prescribing information for RIASTAP. RIASTAP, Fibrinogen Concentrate (Human) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 200920251229